Cargando…

Asymptomatic necrotizing myositis in a young male with progressive interstitial lung disease

Necrotizing autoimmune myopathy (NAM) is a rare inflammatory process characterized by bilateral proximal muscle weakness and elevated creatinine kinase levels. It is one of the idiopathic inflammatory myopathies. It can be associated with anti-signal recognition particle (SRP) antibody which is comm...

Descripción completa

Detalles Bibliográficos
Autores principales: Baah, Samantha, Gorgone, Matthew, Lachant, Daniel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7972976/
https://www.ncbi.nlm.nih.gov/pubmed/33747761
http://dx.doi.org/10.1016/j.rmcr.2021.101374
_version_ 1783666749379444736
author Baah, Samantha
Gorgone, Matthew
Lachant, Daniel
author_facet Baah, Samantha
Gorgone, Matthew
Lachant, Daniel
author_sort Baah, Samantha
collection PubMed
description Necrotizing autoimmune myopathy (NAM) is a rare inflammatory process characterized by bilateral proximal muscle weakness and elevated creatinine kinase levels. It is one of the idiopathic inflammatory myopathies. It can be associated with anti-signal recognition particle (SRP) antibody which is commonly seen in middle-aged females. Classic findings on muscle biopsy include muscle fiber necrosis without inflammation. Pulmonary manifestations associated with anti-SRP NAM is rare, and often a challenging correlation to make as our understanding of inflammatory myopathies and interstitial lung disease is still evolving. There have been some associations of Anti SRP NAM with NSIP which responds to corticosteroids. We present a 29 year old male with asymptomatic NAM who presented with a combination of NSIP and pulmonary arterial hypertension (PAH). His PAH was responsive to oral vasodilator therapy however his interstitial lung disease (ILD) rapidly progressed to usual interstitial pneumonia (UIP) requiring lung transplantation. This case highlights 1) an extremely rare presentation of rapidly progressive NAM associated ILD in a young man, in which pulmonary manifestations occurred in the absence of myopathy, 2) The importance of doing a complete work up for interstitial lung disease, including diligent examination for myopathic features and obtaining CK levels, 3) Identifying that interstitial lung diseases can progress despite control of the underlying etiology with corticosteroids and immunosuppressives, 4) Recognition of pre capillary PAH in patients with disproportionally elevated pressures relative to their pulmonary findings, 5) The first report of treatment responsive pulmonary vascular disease associated with NAM, and 6) The importance of early lung transplantation evaluation.
format Online
Article
Text
id pubmed-7972976
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-79729762021-03-19 Asymptomatic necrotizing myositis in a young male with progressive interstitial lung disease Baah, Samantha Gorgone, Matthew Lachant, Daniel Respir Med Case Rep Case Report Necrotizing autoimmune myopathy (NAM) is a rare inflammatory process characterized by bilateral proximal muscle weakness and elevated creatinine kinase levels. It is one of the idiopathic inflammatory myopathies. It can be associated with anti-signal recognition particle (SRP) antibody which is commonly seen in middle-aged females. Classic findings on muscle biopsy include muscle fiber necrosis without inflammation. Pulmonary manifestations associated with anti-SRP NAM is rare, and often a challenging correlation to make as our understanding of inflammatory myopathies and interstitial lung disease is still evolving. There have been some associations of Anti SRP NAM with NSIP which responds to corticosteroids. We present a 29 year old male with asymptomatic NAM who presented with a combination of NSIP and pulmonary arterial hypertension (PAH). His PAH was responsive to oral vasodilator therapy however his interstitial lung disease (ILD) rapidly progressed to usual interstitial pneumonia (UIP) requiring lung transplantation. This case highlights 1) an extremely rare presentation of rapidly progressive NAM associated ILD in a young man, in which pulmonary manifestations occurred in the absence of myopathy, 2) The importance of doing a complete work up for interstitial lung disease, including diligent examination for myopathic features and obtaining CK levels, 3) Identifying that interstitial lung diseases can progress despite control of the underlying etiology with corticosteroids and immunosuppressives, 4) Recognition of pre capillary PAH in patients with disproportionally elevated pressures relative to their pulmonary findings, 5) The first report of treatment responsive pulmonary vascular disease associated with NAM, and 6) The importance of early lung transplantation evaluation. Elsevier 2021-03-02 /pmc/articles/PMC7972976/ /pubmed/33747761 http://dx.doi.org/10.1016/j.rmcr.2021.101374 Text en © 2021 The Authors. Published by Elsevier Ltd. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Case Report
Baah, Samantha
Gorgone, Matthew
Lachant, Daniel
Asymptomatic necrotizing myositis in a young male with progressive interstitial lung disease
title Asymptomatic necrotizing myositis in a young male with progressive interstitial lung disease
title_full Asymptomatic necrotizing myositis in a young male with progressive interstitial lung disease
title_fullStr Asymptomatic necrotizing myositis in a young male with progressive interstitial lung disease
title_full_unstemmed Asymptomatic necrotizing myositis in a young male with progressive interstitial lung disease
title_short Asymptomatic necrotizing myositis in a young male with progressive interstitial lung disease
title_sort asymptomatic necrotizing myositis in a young male with progressive interstitial lung disease
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7972976/
https://www.ncbi.nlm.nih.gov/pubmed/33747761
http://dx.doi.org/10.1016/j.rmcr.2021.101374
work_keys_str_mv AT baahsamantha asymptomaticnecrotizingmyositisinayoungmalewithprogressiveinterstitiallungdisease
AT gorgonematthew asymptomaticnecrotizingmyositisinayoungmalewithprogressiveinterstitiallungdisease
AT lachantdaniel asymptomaticnecrotizingmyositisinayoungmalewithprogressiveinterstitiallungdisease